https://www.selleckchem.com/pr....oducts/dlin-kc2-dma.
ed in the high and medium dose groups of SXXBC and indirubin (P＜0.05), and the fibrinogen (FI content in the high and medium dose groups of SXXBC was close to that of the normal control group. Both of the SXXBC and the indirubin standard all show good hemostatic effects. Indirubin shows a positive effect on increasing the peripheral platelet and hemoglobin in ITP model mice, regulating the immune response, reducing the total number of bone marrow megakaryocytes, increasing the thromocytogenic megakaryocyte, and increasing coagula
Like
Comment
Share